Paracetamol and High Blood Pressure Medication Fail Quality Test Alert
Wednesday, 25 September 2024, 09:55
Recent Quality Test Findings
The Central Drug Standard Control Organization (CDSCO) has reported a significant failure in drug quality standards. Paracetamol and various other drugs, including anti-diabetic treatments, have been identified as ‘not of standard quality’ in their latest inspection.
Details of the Findings
- Paracetamol was among 53 medicines listed for inadequate quality.
- Other medications include high blood pressure medication.
- This has led to a widespread nsq alert by the CDSCO.
Healthcare professionals are advised to review their supply of these medications and ensure patient safety. For ongoing updates, potential regulatory actions, and guidelines on alternative treatments, it's crucial to stay informed.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.